ClinicalTrials.Veeva

Menu

Percutaneous Cryoablation of Central Kidney Tumours With Temporary Renal Artery Occlusion (CP-Renal)

U

University Hospital, Strasbourg, France

Status

Completed

Conditions

Kidney Cancer

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Percutaneous cryoablation is an alternative to urological surgery for T1a tumours, whose oncological efficacy decreases for the most central tumours due to a cold sink effect.

Enrollment

16 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria:

  • Adult subject (≥18 years)
  • Subject who has undergone cryoablation of a central kidney tumour with temporary occlusion of the renal artery by an endovascular balloon at the HUS during the period 01/01/2018 to 30/12/2021
  • Subject who has not expressed his/her opposition, after information, to the re-use of his/her data for the purpose of this research.

Exclusion criteria :

  • Subject having expressed his/her opposition to participate in the study
  • Subject under legal protection, guardianship or curatorship

Trial contacts and locations

1

Loading...

Central trial contact

Saïd CHAYER, PhD, HDR; Pierre-Alexis AUTRUSSEAU, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems